Terms: = Lung cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
23 results:
1. Combined Inhibition of ezh2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
2. Integrative Analysis of Ferroptosis-Related Genes in Small Cell lung cancer for the Identification of Biomarkers and Therapeutic Targets.
Yunchu Y; Miyanaga A; Seike M
Front Biosci (Landmark Ed); 2023 Jun; 28(6):125. PubMed ID: 37395033
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract] [Full Text] [Related]
4. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
5. Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology.
Girolami I; Lucenteforte E; Eccher A; Marletta S; Brunelli M; Graziano P; Pisapia P; Malapelle U; Troncone G; Scarpa A; Huang T; Pantanowitz L
Cancer Cytopathol; 2022 Feb; 130(2):96-109. PubMed ID: 34478240
[TBL] [Abstract] [Full Text] [Related]
6. The Role of Tumor-related LncRNA PART1 in cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract] [Full Text] [Related]
7. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
[TBL] [Abstract] [Full Text] [Related]
8. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by ezh2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract] [Full Text] [Related]
9. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract] [Full Text] [Related]
10. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
Chapel DB; Churg A; Santoni-Rugiu E; Tsujimura T; Hiroshima K; Husain AN
Lung Cancer; 2019 Jan; 127():69-75. PubMed ID: 30642555
[TBL] [Abstract] [Full Text] [Related]
11. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
12. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression.
Chen Z; Chen X; Chen P; Yu S; Nie F; Lu B; Zhang T; Zhou Y; Chen Q; Wei C; Wang W; Wang Z
Cell Death Dis; 2017 Oct; 8(10):e3092. PubMed ID: 28981099
[TBL] [Abstract] [Full Text] [Related]
14. Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
Brown RE; Buryanek J; McGuire MF
Ann Clin Lab Sci; 2017 Aug; 47(4):457-465. PubMed ID: 28801373
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic utility of BAP1 and ezh2 expression in malignant mesothelioma.
Shinozaki-Ushiku A; Ushiku T; Morita S; Anraku M; Nakajima J; Fukayama M
Histopathology; 2017 Apr; 70(5):722-733. PubMed ID: 27859460
[TBL] [Abstract] [Full Text] [Related]
16. Long Noncoding RNA PVT1 Promotes Non-Small Cell lung cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract] [Full Text] [Related]
17. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study.
Liu HW; Gabos Z; Ghosh S; Roberts B; Lau H; Kerba M
Radiother Oncol; 2015 Oct; 117(1):71-6. PubMed ID: 26349589
[TBL] [Abstract] [Full Text] [Related]
19. Screening of critical genes in lung adenocarcinoma via network analysis of gene expression profile.
Huang P; Cao K; Zhao H
Pathol Oncol Res; 2014 Oct; 20(4):853-8. PubMed ID: 24859971
[TBL] [Abstract] [Full Text] [Related]
20. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.
Zhang EB; Yin DD; Sun M; Kong R; Liu XH; You LH; Han L; Xia R; Wang KM; Yang JS; De W; Shu YQ; Wang ZX
Cell Death Dis; 2014 May; 5(5):e1243. PubMed ID: 24853421
[TBL] [Abstract] [Full Text] [Related]
[Next]